-
Nigeria's Tinubu confirms 32 dead after military plane crash
-
Putin allows Italy's UniCredit to sell part of Russian business
-
'Reckless' AI firms can't control models, says whistleblower
-
Djokovic into China Open final as Medvedev out for hitting fan with ball
-
Switching on brain cells: the Nobel-winning science of optogenetics
-
ICC unseals arrest warrants for Taliban education ministers
-
Quebec votes as separatist surge poses test for Canada PM
-
Modric hopes fans back Croatia against Spain after England shame
-
Euro slides as concerns about French debt mount
-
Bolsonaro rides right-wing surge into Brazil's election runoff
-
Former Trump press secretary Leavitt joins Fox News
-
Turkey blocks X account of British reporter
-
Djokovic advances to China Open final as Medvedev out for hitting fan with ball
-
Ukraine says using AI robot guns to shoot down new Russian drones
-
Disgraced former US House speaker dies at 84
-
At Oct 7 memorial, Netanyahu says will be no Hamas rule in Gaza
-
Euro slides as worries about French debt grow
-
Ukraine blames Russia for deadly sinking of Turkish ship in Black Sea
-
US withdraws all bomber aircraft from UK airbase
-
UN rights council slams Taliban's 'oppression' of women
-
Drone hits Ethiopia IDP camp as fears grow of regional war
-
Norway eyes partial ban of smart glasses
-
US-German trio wins medicine Nobel for illuminating the brain
-
Two dead after ship catches fire, sinks in Black Sea
-
England captain Kane driven by desire for records says Tuchel
-
Spain's PM calls snap election after housing bill defeat
-
N.Irish court hears challenge to disputed Orangemen parade
-
STARCARES Equips Seven Foster Homes for Children and Young People in Tanzania
-
Talking points from the Bahrain Grand Prix in Malaysia
-
Alleged Indian leader of neo-Nazi child abuse ring goes on trial in Paris
-
Yemen, Saudi Arabia target Houthis in new campaign as war escalates
-
Euro, French stocks slide on France debt concerns
-
US-German trio wins medicine Nobel for work on optogenetics
-
Alcaraz advances to Japan Open final
-
Swiatek, Zheng survive three-set tests in China Open third round
-
US-German trio win medicine Nobel for work on optogenetics
-
Hasan says Test cricket momentum turning for Bangladesh
-
Hundreds of French high schools shut as protests persist
-
Intense heat puts births in jeopardy, UN tells Fiji talks
-
Spain PM calls early election after housing crisis defeat
-
US arrests woman accused of spying for China on Taiwan leader's family
-
Stocks rally as 'Goldilocks' jobs data ease rate fears
-
Yemen military announces broad strikes against Houthis
-
Myanmar says 10,000 migrants returned from Malaysia this year
-
Zuckerberg skewered again on screen in 'The Social Reckoning'
-
Big guns back for Australia's Rugby League World Cup defence
-
Fiji urges 'just' climate transition, financing at pre-COP gathering
-
Braves rock Dodgers to level series, Brewers win thriller
-
Thailand's Jeeno overcomes late wobble to win Lotte Championship
-
Most Asia stocks rally as 'Goldilocks' jobs data ease rate fears
EssilorLuxottica sales slide as investors turn wary of AI glasses
Shares in EssilorLuxottica, the world's top maker of eyeglasses, slid on Thursday as analysts said investors have turned wary of AI glasses.
The French-Italian company has pushed hard into wearable tech and has a tie-up with Meta for its Ray-Ban AI glasses.
The nearly five percent drop in morning trading in Paris, whose overall market was up 0.1 percent, came despite the company posting Wednesday evening a 4.1 percent increase in first quarter sales to 7.1 billion euros ($8.3 billion).
EssilorLuxottica did not provide a breakdown of AI glasses, but said they supported growth and the launch of Ray-Ban Meta’s new optical-first styles had been a success.
EssilorLuxottica's foray into "AI glasses is now seen as a source of risk, after initially being viewed as a major opportunity," analysts at Oddo BHF said in a note.
"Following very satisfactory performance in previous quarters, the stock is going through a tougher patch in 2026," they added.
While first quarter sales met analyst expectations, and represented a gain of 10.8 percent on an organic basis -- that is stripping out the effects of changes in exchange rates and in business operations.
But "given the macroeconomic uncertainties, we are cautiously lowering our expectations for organic growth in 2026 from 10 to nine percent," said analysts at Jefferies.
EssilorLuxottica does not provide detailed sales and earnings guidance.
N.Shalabi--SF-PST